Risk factors for recurrence of scabies: A retrospective study of scabies patients in a long-term care hospital

Journal of Dermatology

Volumn 38, Issue 9, 2011, Pages 874-879

  Makigami, Kuniko ^a   Ohtaki, Noriko ^b   Ishii, Norihisa ^c   Tamashiro, Tetsuko ^d   Yoshida, Sadao ^e   Yasumura, Seiji ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b Kudanzaka Hospital   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^d Departments of Pharmacy   (Japan)

^e University of Occupational and Environmental Health School of Medicine   (Japan)

Author keywords

epidemiology; long term care hospital; re infestation; recurrence; scabies

Indexed keywords

CROTAMITON; IVERMECTIN; LINDANE; PERMETHRIN; SULFUR;

AGED; ARTICLE; COMORBIDITY; CORTICOSTEROID THERAPY; DEMENTIA; DIABETES MELLITUS; DISEASE SEVERITY; DRUG USE; FEMALE; HOSPITAL PATIENT; HOSPITAL PERSONNEL; HUMAN; INFESTATION; LONG TERM CARE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PARASITIC SKIN DISEASE; RECURRENCE RISK; RECURRENT DISEASE; REHABILITATION CENTER; RETROSPECTIVE STUDY; SCABIES; TUBE FEEDING;

ACARICIDES; ADMINISTRATION, TOPICAL; AGED; AGED, 80 AND OVER; DEMENTIA; FEMALE; HOSPITALS; HUMANS; JAPAN; LONG-TERM CARE; MALE; PREVALENCE; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SCABIES; TIME FACTORS;

EID: 80052055558     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2011.01199.x     Document Type: Article

References (14)

1. Green MS,. Epidemiology of scabies. Epidemiol Rev 1989; 11: 126-150. (Pubitemid 19279010)
2. Ohtaki N,. [Epidemiology of scabies in institutions for the elderly in Japan (in Japanese)]. Hifubyo Shinryo 1997; 19: 468-472.
3. Makigami K, Ohtaki N, Ishii N, Yasumura S,. Risk factors of scabies in psychiatric and long long-term care hospitals: a nation-wide mail-in survey in Japan. J Dermatol 2009; 36: 491-498; in press.
4. Lettau LA,. Nosocomial transmission and infection control aspects of parasitic and ectoparasitic diseases. Part III. Ectoparasites/summary and conclusions. Infect Control Hosp Epidemiol 1991; 12: 179-185.
5. Makigami K, Ohtaki N, Yasumura S,. [Do patient transfers increase the risk of scabies introduction?: 35-month prospective study in a psychiatric hospital (in Japanese)]. Nippon Koshu Eisei Zasshi 2006; 53: 929.
6. Executive committee of guideline for diagnosis, Ishii N,. Guideline for the diagnosis and treatment of scabies in Japan (second edition). J Dermatol 2008; 35: 378-393. (Pubitemid 351840243)
7. Tjioe M, Vissers WH,. Scabies outbreaks in nursing homes for the elderly: recognition, treatment options and control of reinfestation. Drugs Aging 2008; 25: 299-306. (Pubitemid 351440448)
8. Currie BJ, Harumal P, McKinnon M, Walton SF,. First documentation of in vivo and in vitro ivermectin resistance in Sarcoptes scabiei. Clin Infect Dis 2004; 39: 8-12.
9. van den Hoek J, van de Weerd J, Baayen T, et al. A persistent problem with scabies in and outside a nursing home in Amsterdam: indications for resistance to lindane and ivermectin. Euro Surveill 2008; 13: 1-2.
10. Walton SF, McBroom J, Mathews JD, Kemp DJ, Currie BJ,. Crusted scabies: a molecular analysis of Sarcoptes scabiei variety hominis populations from patients with repeated infestations. Clin Infect Dis 1999; 29: 1226-1230. (Pubitemid 30265643)
11. Taniguchi Y, Higashiguchi T, Futamura A, et al. [Significance of peripheral differential count of lymphocytes for opportunistic infection and value of enteral nutrition (in Japanese)]. Geka to Taisya Eiyou 2000; 34: 146.
12. Strong M, Johnstone P,. Interventions for treating scabies. Cochrane Database Syst Rev 2007; 3: Art. No.: CD000320. DOI:.
13. Mounsey KE, Holt DC, McCarthy J, Currie BJ, Walton SF,. Scabies: molecular perspectives and therapeutic implications in the face of emerging drug resistance. Future Microbiol 2008; 3: 57-66. (Pubitemid 351385951)
14. Currie BJ, McCarthy JS,. Permethrin and ivermectin for scabies. N Engl J Med 2010; 362: 717-725.